Literature DB >> 27973326

Asthma exacerbations in a tertiary hospital: clinical features, triggers, and risk factors for hospitalization.

B Pola-Bibian1, J Dominguez-Ortega1,2, G Vilà-Nadal1, A Entrala1, L González-Cavero1, P Barranco1,2, N Cancelliere3, M Díaz-Almirón4, S Quirce1,2.   

Abstract

BACKGROUND: Risk factors for asthma exacerbations are not fully understood. The aim of this study was to determine the epidemiological and clinical characteristics of patients with an asthma exacerbation, potential triggers, and possible predictors of hospitalization.
METHODS: A retrospective, non-interventional cohort study was conducted in adult patients who attended the Emergency Department of a tertiary hospital with an asthma exacerbation during 2014.
RESULTS: 831 patients (888 events) were included. The highest number of episodes occurred in January and May. Respiratory infection was considered the trigger in 523 events. 34.21% had ≥260 eosinophils/mm3 (20.7%≥400 eosinophils/mm3), significantly associated with allergic asthma (p<0.0001). Risk factors for hospitalization were: older age [OR:1.58 (95% CI 1.46-1.71)]; no previous diagnosis of asthma [OR:1.40(95% CI 1.06-1.86)]; poorly controlled asthma[OR:1.78 (95% CI 1.10-2.88)]; respiratory infection [OR:2.65 (95% CI 1.95-3.62)]; and severe crisis with more treatment requirements. Of those asthmatics with ≥400 eosinophils/mm3, the rate of hospitalization was lower (p<0.001).
CONCLUSION: Older age, absence of a previous asthma diagnosis, uncontrolled disease or concomitant COPD are frequent among patients presenting to the ED with asthma exacerbations. There were some features associated with higher risk of admission. Blood eosinophilia should be considered as a marker of asthma, but not as a predictor of hospitalization.

Entities:  

Keywords:  Asthma. Exacerbation. Risk of hospital admission. Eosinophilia.

Year:  2016        PMID: 27973326     DOI: 10.18176/jiaci.0128

Source DB:  PubMed          Journal:  J Investig Allergol Clin Immunol        ISSN: 1018-9068            Impact factor:   4.333


  6 in total

Review 1.  Integration of in vitro allergy test results and ratio analysis for the diagnosis and treatment of allergic patients (INTEGRA).

Authors:  Mariona Pascal; Carmen Moreno; Ignacio Dávila; Ana I Tabar; Joan Bartra; Moisés Labrador; Olga Luengo
Journal:  Clin Transl Allergy       Date:  2021-08       Impact factor: 5.657

2.  Can eosinophilia and neutrophil-lymphocyte ratio predict hospitalization in asthma exacerbation?

Authors:  Hossein Esmaeilzadeh; Fatemeh Nouri; Seyed Hesamodin Nabavizadeh; Soheila Alyasin; Negar Mortazavi
Journal:  Allergy Asthma Clin Immunol       Date:  2021-02-10       Impact factor: 3.406

3.  Determinants of Asthma Attack Among Adult Asthmatic Patients Attending at Public Hospitals of West Shoa Zone, Oromia Regional State, Ethiopia, 2021: Case-Control Study.

Authors:  Shiferaw Megersa; Getahun Chala; Kena Fikremariam
Journal:  J Asthma Allergy       Date:  2022-08-24

4.  Association between blood eosinophil count and risk of readmission for patients with asthma: Historical cohort study.

Authors:  Marjan Kerkhof; Trung N Tran; Maarten van den Berge; Guy G Brusselle; Gokul Gopalan; Rupert C M Jones; Janwillem W H Kocks; Andrew Menzies-Gow; Javier Nuevo; Ian D Pavord; Sarang Rastogi; David B Price
Journal:  PLoS One       Date:  2018-07-25       Impact factor: 3.240

5.  Determinants of Acute Asthma Attack among adult asthmatic patients visiting hospitals of Tigray, Ethiopia, 2019: case control study.

Authors:  Melaku Negash; Hagos Tsegabrhan; Teklit Meles; Degena Bahrey Tadesse; Gebreamlak Gidey; Yemane Berhane; Kibrom Berhanu; Tsgalem Haylemaryam
Journal:  Asthma Res Pract       Date:  2020-04-03

6.  Population pharmacokinetic analysis of dupilumab in adult and adolescent patients with asthma.

Authors:  Li Zhang; Yue Gao; Meng Li; Christine Xu; John D Davis; Vanaja Kanamaluru; Qiang Lu
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2021-07-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.